Ongoing studies into this medication are yielding significant outcomes regarding body composition . Initially created for treating type 2 diabetes , this GLP-1 receptor agonist has shown considerable https://socialfactories.com/story7051037/semaglutide-research-unlocking-emerging-weight-loss-potential